A LiquidText Case Study

Maiwald makes the case for patent lawyers to learn something new: LiquidText

An Interview with Dr. Eva Ehlich, Partner, Shareholder, Managing Director, Maiwald Intellectual Property

s Screen Shot 2022-12-27 at 1.20.00 PM.jpg

As published in December 2023 in Patent Lawyer Magazine, Click the image to read.

How a Patent Attorney has revolutionized her practice with LiquidText

Influenced by several years of use, Dr Eva Ehlich, Partner, Shareholder, and Managing Director at Maiwald, expresses why LiquidText is the ‘it’ software for patent attorneys owing to its advanced capabilities for thought tracking and instant recall across entire project areas.
Eva represents European, US and Japanese companies in the chemical, biochemical and pharmaceutical sectors whom she advises and assists in drafting, prosecuting, defending, enforcing and challenging IP rights in Germany, Europe and worldwide. Along with preparing freedom-to-operate and validity analyses she has experience in patent litigation and strategic patent filing, especially in the area of drug delivery, pharmaceutics and medical uses (small molecules and biologics) as well as in coordinating international patent portfolios and freedom-to-operate strategies. Eva has received numerous recognitions for her professional activities as a patent attorney.